Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression
2002; Elsevier BV; Volume: 100; Issue: 6 Linguagem: Inglês
10.1182/blood-2002-06-1811
ISSN1528-0020
AutoresOliver Bock, Jérôme Schlué, Ulrich Lehmann, Reinhard von Wasielewski, Florian Länger, Hans Kreipe,
Tópico(s)Eosinophilic Disorders and Syndromes
ResumoChronic myeloproliferative disorders (CMPDs) comprising chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), and chronic idiopathic myelofibrosis (IMF) differ in their potential for resulting in bone marrow fibrosis. In IMF, fibrosis usually starts developing in
Referência(s)